| scholarly article | Q13442814 |
| P50 | author | Sjur Olsnes | Q17106311 |
| P2093 | author name string | Eiklid K | |
| Reisbig R | |||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8739-8744 | |
| P577 | publication date | 1981-08-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit | |
| P478 | volume | 256 |
| Q39543360 | 4-Aminopyrazolo[3,4-d]pyrimidine (4-APP) as a novel inhibitor of the RNA and DNA depurination induced by Shiga toxin 1 |
| Q35104239 | A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit |
| Q37401976 | A yeast killer toxin screen provides insights into a/b toxin entry, trafficking, and killing mechanisms |
| Q33363266 | Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome |
| Q33501527 | Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies |
| Q24634587 | Bacterial toxins: cellular mechanisms of action |
| Q37031424 | Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli |
| Q39654288 | Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells |
| Q37020358 | Cytotoxicity of Shiga toxin for primary cultures of human colonic and ileal epithelial cells |
| Q36999010 | Direct cytotoxic action of Shiga toxin on human vascular endothelial cells |
| Q37215545 | Effects of cycloheximide and puromycin on cytotoxic activity of Escherichia coli verocytotoxin (Shiga-like toxin). |
| Q41685673 | Endocytosis and intracellular transport of the glycolipid-binding ligand Shiga toxin in polarized MDCK cells |
| Q41575546 | Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1. |
| Q40182540 | Entry of Shigella dysenteriae toxin into HeLa cells |
| Q37207255 | Enzyme-linked immunosorbent assay for shigella toxin. |
| Q24651553 | Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I |
| Q35779632 | Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity |
| Q34544688 | Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells |
| Q33946874 | Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications |
| Q33288090 | Identification and characterization of small molecules that inhibit intracellular toxin transport |
| Q93087975 | Immunological detection assays for recombinant Shiga toxin & Shigella dysenteriae |
| Q37006892 | In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity |
| Q36634680 | Infection by verocytotoxin-producing Escherichia coli |
| Q50205608 | Infectious diarrhea. Pathogenesis and risk factors |
| Q40162448 | Ionic requirements for entry of Shiga toxin from Shigella dysenteriae 1 into cells |
| Q37110126 | Isolation and characterization of monoclonal antibodies to Shiga toxin |
| Q40158837 | Isolation of Shiga toxin-resistant Vero cells and their use for easy identification of the toxin |
| Q33721760 | Membrane receptors for bacterial toxins |
| Q36103964 | Minimum domain of the Shiga toxin A subunit required for enzymatic activity |
| Q35836549 | Morphologic evaluation of the effects of Shiga toxin and E coli Shiga-like toxin on the rabbit intestine |
| Q33411089 | Mouse in vivo neutralization of Escherichia coli Shiga toxin 2 with monoclonal antibodies |
| Q37027574 | Natural and recombinant interferons inhibit epithelial cell invasion by Shigella spp. |
| Q36265701 | Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. |
| Q34633814 | Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli |
| Q36349737 | Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. |
| Q34578986 | Pathogenesis of Shigella diarrhea. XVI. Selective targetting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport |
| Q38350915 | Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide |
| Q33406825 | Prophage induction is enhanced and required for renal disease and lethality in an EHEC mouse model |
| Q40856041 | Protein toxins acting on intracellular targets: cellular uptake and translocation to the cytosol |
| Q41191533 | Purification and biological characterization of shiga toxin from Shigella dysenteriae 1. |
| Q37112219 | Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli |
| Q33397981 | Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes |
| Q34033376 | Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia |
| Q36105481 | Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol |
| Q34363235 | Role of iron in regulation of virulence genes |
| Q36973479 | Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin |
| Q37063416 | Shiga and Shiga-like toxins |
| Q33384145 | Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro |
| Q33808280 | The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory response |
| Q38022246 | The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety? |
| Q40421134 | The mechanism of action of trichosanthin on eukaryotic ribosomes--RNA N-glycosidase activity of the cytotoxin |
| Q42856082 | The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis |
| Q28770107 | The operator and early promoter region of the Shiga toxin type 2-encoding bacteriophage 933W and control of toxin expression |
| Q54648744 | The role of tyrosine-114 in the enzymatic activity of the Shiga-like toxin I A-chain. |
| Q39820812 | Toxin production by Campylobacter spp. |
| Q24646436 | Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities |
| Q39515644 | mkp-1 encoding mitogen-activated protein kinase phosphatase 1, a verotoxin 1 responsive gene, detected by differential display reverse transcription-PCR in Caco-2 cells |
Search more.